【Synergy Medical】Announcement of Board Approval of Q1 2026 Consolidated Financial Report
Key facts
- 【Synergy Medical】Announcement of Board Approval of Q1 2026 Consolidated Financial Report
- Synergy Medical announced that its board of directors approved the consolidated financial report for the first quarter of 2026. The report shows operating revenue of NT$1,160,484 thousand, net profit attributable to owners of the parent company of NT$26,195 thousand, and basic EPS of NT$0.13, confirming the company's solid financial health.
- Source: PR Times
- Date: May 6, 2026
Direct answer
Synergy Medical announced that its board of directors approved the consolidated financial report for the first quarter of 2026. The report shows operating revenue of NT$1,160,484 thousand, net profit attributable to owners of the parent company of NT$26,195 thousand, and basic EPS of NT$0.13, confirming the company's solid financial health.
- Citation
- 【Synergy Medical】Announcement of Board Approval of Q1 2026 Consolidated Financial Report (May 6, 2026), PR Times
- Source
- PR Times
- Date
- May 6, 2026
Synergy Medical announced that its board of directors approved the consolidated financial report for the first quarter of 2026. The report shows operating revenue of NT$1,160,484 thousand, net profit attributable to owners of the parent company of NT$26,195 thousand, and basic EPS of NT$0.13, confirming the company's solid financial health.
📋 Article Processing Timeline
- 📰 Published: May 6, 2026 at 09:00
- 🔍 Collected: May 7, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 7, 2026 at 08:17 (17 min after Collected)
2. Date of approval by the audit committee: 2026/05/06
3. Reporting period for financial report or annual self-reported financial information (YYYY/MM/DD~YYYY/MM/DD): 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 1,160,484
5. Cumulative operating gross profit (loss) from January 1 to the end of this period (in thousands of NTD): 268,404
6. Cumulative operating income (loss) from January 1 to the end of this period (in thousands of NTD): 77,158
7. Cumulative net profit before tax (loss) from January 1 to the end of this period (in thousands of NTD): 51,273
8. Cumulative net profit (loss) for this period from January 1 to the end of this period (in thousands of NTD): 36,246
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 26,195
10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.13
11. Total assets at the end of the period (in thousands of NTD): 15,956,285
12. Total liabilities at the end of the period (in thousands of NTD): 8,078,503
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 7,447,429
14. Other matters that should be specified: None.
FAQ
What are the key facts in this article?
Synergy Medical announced that its board of directors approved the consolidated financial report for the first quarter of 2026. The report shows operating revenue of NT$1,160,484 thousand, net profit attributable to owners of the parent company of NT$26,195 thousand, and basic EPS of NT$0.13, confirming the company's solid financial health.
What is the direct answer?
Synergy Medical announced that its board of directors approved the consolidated financial report for the first quarter of 2026. The report shows operating revenue of NT$1,160,484 thousand, net profit attributable to owners of the parent company of NT$26,195 thousand, and basic EPS of NT$0.13, confirming the company's solid financial health.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-4164-2026-05-06-50efbf2d | May 6, 2026